Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1) is a processed pseudogene with high sequence similarity to the functional HMGN3 gene. Pseudogenes are nonfunctional copies of genes or gene fragments that arose from duplication or retrotransposition events in the genome and generally do not encode proteins. While some pseudogenes can regulate gene expression of their parental genes through non-coding RNA mechanisms, there is no specific evidence that HMGN3P1 is functionally active or implicated in disease pathways. In contrast to true therapeutic targets, pseudogenes like HMGN3P1 are primarily studied as genomic elements with potential regulatory roles rather than druggable proteins.
None known or reported for drugs, since it is not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1).